SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : Tokyo Joe's Cafe / Societe Anonyme/No Pennies -- Ignore unavailable to you. Want to Upgrade?

To: Frost Byte who wrote (55178)2/12/1999 5:32:00 AM
From: Manfred  Respond to of 119973
 
ENMD: will BMY come back soon?

From today's NY Times:

"A spokesman for Bristol-Myers
Squibb said the company might resume its involvement with angiostatin if
Entremed could develop a reliable manufacturing process and make a
form of angiostatin that proved safe and effective."

Manfred



To: Frost Byte who wrote (55178)2/12/1999 6:23:00 AM
From: hoffy  Read Replies (2) | Respond to of 119973
 
The cancer companies should be very hot today. IMCL looks to benefit greatly especially with their late news yeterday. C'mon Joe, give us some play on CNBC. Very possible later today with their news out and the whole ENMD story. I can see him mentioning IMLC's drug going into phase three trials with the bacing of Merck. Great story, great company in a hot sector.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News